(Q33807671)

29 July 2017

1 reference

title

Diuretics and beta-blockers: is there a risk for dyslipidemia? (English)

1 reference

29 July 2017

1 reference

Weir MR

1

1 reference

29 July 2017

Moser M

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 July 2017

published in

American Heart Journal

1 reference

29 July 2017

volume

139

1 reference

29 July 2017

issue

1 Pt 1

1 reference

29 July 2017

page(s)

174-183

1 reference

A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Evidence for the efficacy of low-dose diuretic monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

The triglyceride issue: a view from Framingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Increase in serum-lipids during treatment of hypertension with chlorthalidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effects of diuretics on lipid metabolism in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Why are physicians not prescribing diuretics more frequently in the management of hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Antihypertensive agents, serum lipoproteins and glucose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Menopause-dependent plasma lipoprotein alterations in diuretic-treated women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Metabolic manifestations of low-dose diuretics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Guidelines for the treatment of hypertension: an American view. Fifth Joint National Committee.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

Adrenergic mechanisms in control of plasma lipid concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990325-9

10.1016/S0002-8703(00)90325-9

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference